New 'armored' CAR produces responses in patients whose cancers don't respond to current CAR T cell therapies
While CAR T cell therapy has revolutionized treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many patients who receive CAR T cell therapy do not experience a long-term remission. For those whose cancers ...
Jun 1, 2024
0
2